Sort by
Refine Your Search
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
. The ideal candidate will have experience in developing LC-MS-based methods, troubleshooting instrumentation, processing complex data, and creating SOPs for metabolite and lipid identification. As a successful
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
cell treatments. · Perform data analysis using statistical and computational methods. · Develop and implement mathematical models to understand and predict treatment outcomes
-
computational pipelines to integrate genomic, transcriptomic, and clinical data from both tissue and liquid biopsies Be responsible for the development and execution of major research projects, as
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center